Finance and markets: business, quotes, gold, energy and releases.
Found 4733 articles
After two decades navigating the complexities of biotechnology finance, Eric Hyllengren is stepping into the role of chief financial officer at Tenaya Therapeutics. Starting July 13, he will take charge of the company’s capital allocation and corporate strategy as it pushes its cardiovascular research toward clinical milestones.
Shares of Evommune plummeted 29% in premarket trading Monday after the biotechnology firm reported that its experimental drug, EVO756, failed to meet primary efficacy goals in a Phase 2b study targeting chronic spontaneous urticaria, a condition characterized by persistent, debilitating hives that resist standard antihistamine treatments.
Shares of drone-autonomy software firm Swarmer surged 7.2% to $43.95 in Monday’s premarket trading, following a disclosure that an existing contract will generate an additional $1.02 million in revenue. The company, which debuted on the public market at $5 per share in March, continues to see rapid valuation growth.
After holding the top spot for just over a year, Copart CEO Jeff Liaw will vacate his position at the end of July. The Dallas-based online vehicle auction firm announced Monday that Executive Chairman Jay Adair is returning to the chief executive role, effectively reversing the leadership structure established in 2022.
One share of the newly independent Honeywell Aerospace for every two shares of the former parent company: that is the math behind the industrial giant’s final structural pivot. The move formally concludes a multiyear effort to unwind Honeywell’s sprawling conglomerate model into a leaner, specialized operation.
A key European regulatory committee has recommended expanding the approval of AbbVie’s blockbuster drug Rinvoq to treat severe alopecia areata and non-segmental vitiligo. If the European Commission follows this advice, the medication would become the first systemic treatment option available across Europe for patients battling the most common form of vitiligo.
Vancouver-based Zymeworks has reached an agreement to acquire Theravance Biopharma for approximately $929 million, a move centered on the acquisition of the chronic obstructive pulmonary disease treatment Yupelri. The all-cash offer arrives just months after a failed clinical trial forced Theravance to overhaul its business strategy.
A $752 million acquisition of Cardinal Midstream Partners’ operating subsidiaries will bolster San Mateo Midstream’s footprint across the Delaware Basin. The deal, announced Monday, integrates a cryogenic processing plant and 145 miles of pipeline into the joint venture’s existing infrastructure, signaling a significant expansion of its gathering and processing capabilities.
A 12% jump in share price propelled Bridgepoint Group to the top of the Stoxx 600 index on Tuesday after the firm announced its acquisition of Kayne Anderson Real Estate. The $1.39 billion deal marks a significant expansion for the London-listed investment company, pushing its total assets under management to $117 billion.
Private equity giant CVC Capital Partners is moving to acquire Italian ingredients manufacturer Irca from Advent, marking another significant expansion in the food production sector. The deal follows a period of rapid scaling for the business, which has seen its annual revenue quadruple under its previous ownership to 1.5 billion euros.
A lightning-sparked wildfire burning near the Larocque East uranium project in northern Saskatchewan has forced IsoEnergy to pull its field crews from the site. While the blaze does not currently threaten the infrastructure directly, the company deemed the surrounding conditions too hazardous to continue active exploration work.
With shares surging 23% in premarket trading, Comcast revealed plans to carve its massive empire into two distinct entities. The move effectively separates the company’s struggling legacy broadband and cable operations from its high-growth media portfolio, marking a definitive pivot for the entertainment titan.
With an $8 billion price tag, Rocket Lab is moving to absorb satellite operator Iridium Communications, a deal that fuses launch capabilities with a global orbital network. The acquisition represents a major consolidation in the American space sector, aiming to integrate spacecraft manufacturing with established on-orbit communications infrastructure.
A sharp rotation in Chinese equity markets saw investors abandon overstretched artificial intelligence stocks on Monday, pouring capital into the healthcare sector instead. The shift triggered one of the most significant single-day rallies for biotech indices in two years, leaving tech-heavy benchmarks trailing behind.
A 0.6% climb in S&P 500 futures sets a positive tone for Wall Street, contrasting with a fragmented session across European exchanges. While investors navigate shifting bond yields, Brent crude prices pushed toward $73 a barrel, reflecting a broader appetite for risk in early trading across Asian and American markets.
Diamond Electric Holdings Co. Ltd. reported a significant contraction in net profit for the fiscal year ending March 31, 2026, as the company’s bottom line fell to 217 million yen from 411 million yen in the previous year, despite a moderate rise in overall top-line revenue.
A 0.9 percent dip in net profit to 2.05 billion yen marks a challenging nine-month period for Nagaileben Co. Ltd. through May 31. While the Tokyo-listed medical apparel manufacturer faced broader revenue contraction, the company managed to boost its per-share earnings to 67.86 yen, up from 66.53 yen in the previous year.
Zojirushi Corp. saw its net profit climb to 3.53 billion yen for the six-month period ending May 20, up from 3.40 billion yen in the same timeframe last year. The Japanese kitchenware manufacturer bolstered its bottom line as revenue reached 51.21 billion yen, reflecting steady demand for its premium product lineup.
Shimamura Co. reported a significant jump in first-quarter net profit to 12.86 billion yen, up from 10.80 billion yen during the same period last year. The Japanese apparel retailer saw its revenue climb to 181.66 billion yen, signaling robust consumer demand as the company navigated the fiscal quarter ending May 20.
Shares of Alebund Pharmaceuticals more than doubled during their Hong Kong market debut Monday, hitting HK$45.70 against an offering price of HK$22.60. The dramatic opening underscores a resurgence in investor appetite for Chinese biotech firms, bolstered by the company's focus on specialized renal therapies.
Oil prices climbed while Asian equities struggled for direction as renewed fighting near the Strait of Hormuz punctured hopes for regional stability. With one-fifth of global crude supply potentially at risk, investors are discounting the possibility of a swift resolution despite U.S. and Iranian plans to resume peace talks Tuesday.
China’s commerce ministry has placed 20 Japanese entities, including major defense contractors and research institutes, under strict export controls. The move, effective immediately, bans local firms from supplying dual-use technologies, citing national security concerns and the alleged role of these organizations in strengthening Japan’s military capabilities.
Beijing has expanded its export control list to include 20 Japanese entities, effectively severing their access to dual-use Chinese goods. The Monday announcement signals a sharp escalation in regional trade friction, targeting key defense contractors and research institutions under the banner of national security and international non-proliferation standards.
Five Chinese technology and AI companies are targeting a combined $1.3 billion in Hong Kong initial public offerings, betting that investor appetite for innovation remains resilient despite the market volatility triggered by geopolitical tensions between the United States and Iran.
Projecting a significant financial shift, GameStop anticipates adjusted earnings before interest, taxes, depreciation, and amortization will exceed $600 million for the fiscal year ending January 30, 2027. This guidance marks a substantial increase from the $345.4 million reported by the retailer for the preceding fiscal year.
A modest rally across the financial sector is currently balancing competing market forces, as optimism surrounding regional bank earnings contends with cooling sentiment in investment banking. Investors are weighing these gains against a broader climate of uncertainty fueled by stalled tech sector momentum and increased regulatory scrutiny.
The Nasdaq Composite retreated more than 6% from its June 2 peak, as investor enthusiasm for the artificial intelligence sector cooled. Market participants are increasingly questioning the sustainability of the AI boom, forcing a reassessment of valuations across high-growth technology portfolios.
Communications services stocks clawed back recent losses today as market participants recalibrated expectations for consumer spending. The sector’s rebound provided a rare bright spot while energy markets slumped, with oil futures settling at their lowest price point since February 27, the eve of the conflict involving Iran.
Valued at approximately $29 billion, the Chicago-based insurance brokerage Hub International has taken its first formal step toward a public debut. The firm submitted a confidential S-1 filing to regulators, signaling a transition toward the public markets while keeping specific financial disclosures under wraps for now.
Stock traders are pivoting toward the stability of power producers, cooling their exposure to artificial intelligence after recent market swings. This defensive rotation highlights a growing investor preference for tangible utility assets as the broader tech sector faces renewed scrutiny and unpredictable price action in the current trading climate.